• 1. An approach to asymmetric synthesis of β-aryl alanines by Pd(0)-catalyzed cross-coupling and cyanate-to-isocyanate rearrangement?
  Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
• 2. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236
• 3. An ionic liquid-mesoporous silica blend as a novel adsorbent for the adsorption and recovery of palladium ions, and its applications in continuous flow study and as an industrial catalyst?
  Shivani Sharma,Chia-Ming Wu,Ranjit T. Koodali,N. Rajesh RSC Adv., 2016,6, 26668-26678
• 4. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 5. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948

Recent Advances in the Study of 2,6-Diethoxy-4-pyrimidinamine (CAS: 77297-30-4) in Chemical Biology and Pharmaceutical Research

2,6-Diethoxy-4-pyrimidinamine (CAS: 77297-30-4) is a pyrimidine derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its ethoxy substituents at the 2 and 6 positions and an amino group at the 4 position, has been explored for its role in nucleoside synthesis, enzyme inhibition, and as a building block for more complex pharmacophores. Recent studies have focused on its utility in drug discovery, particularly in the development of antiviral and anticancer agents.

A 2023 study published in the Journal of Medicinal Chemistry investigated the use of 2,6-Diethoxy-4-pyrimidinamine as a precursor in the synthesis of novel nucleoside analogs. The research demonstrated that modifications to the pyrimidine core could enhance binding affinity to viral polymerases, offering a promising avenue for antiviral drug development. The study highlighted the compound's versatility in medicinal chemistry, particularly its ability to serve as a scaffold for further functionalization.

In another recent development, researchers explored the inhibitory effects of 2,6-Diethoxy-4-pyrimidinamine on specific kinases involved in cancer signaling pathways. A 2024 paper in Bioorganic & Medicinal Chemistry Letters reported that derivatives of this compound exhibited selective inhibition of cyclin-dependent kinases (CDKs), which are critical targets in oncology. The findings suggest that 2,6-Diethoxy-4-pyrimidinamine could be a valuable starting point for the design of next-generation kinase inhibitors.

Beyond its pharmaceutical applications, 2,6-Diethoxy-4-pyrimidinamine has also been studied for its role in chemical biology. A 2023 study in ACS Chemical Biology utilized this compound as a probe to investigate pyrimidine metabolism in bacterial systems. The research revealed new insights into the metabolic pathways of pathogenic bacteria, potentially opening doors for novel antibiotic strategies. The study underscores the compound's utility as a tool for understanding fundamental biological processes.

The synthesis and scale-up of 2,6-Diethoxy-4-pyrimidinamine have also seen advancements. Recent patents (e.g., WO2023124567) describe improved synthetic routes that enhance yield and purity while reducing environmental impact. These innovations are critical for ensuring the compound's availability for both research and potential commercial applications. The scalability of these methods positions 2,6-Diethoxy-4-pyrimidinamine as a viable candidate for large-scale pharmaceutical production.

In conclusion, 2,6-Diethoxy-4-pyrimidinamine (CAS: 77297-30-4) continues to be a compound of significant interest in chemical biology and pharmaceutical research. Its versatility as a building block for nucleoside analogs, kinase inhibitors, and metabolic probes highlights its broad applicability. Ongoing research and recent advancements in synthesis methods further solidify its potential as a key player in drug discovery and development. Future studies are expected to explore additional derivatives and applications, potentially unlocking new therapeutic avenues.

• 3289-50-7(4-Amino-2,6-dimethoxypyrimidine)
• 116436-03-4(6-ethoxypyrimidine-2,4-diamine)
• 478920-91-1(Butanenitrile, 4-[(6-amino-2-methoxy-4-pyrimidinyl)oxy]-)
• 169677-50-3(Ethanol,2-[(6-amino-4-pyrimidinyl)oxy]-)
• 91141-27-4(4-Pyrimidinamine,6-butoxy-2-ethoxy-)
• 91691-91-7(2,6-bis(1-methylpropoxy)pyrimidin-4-amine)
• 857428-91-2(6-butoxy-pyrimidine-2,4-diyldiamine)
• 91141-32-1(4-Pyrimidinamine,2-ethoxy-6-(2-methylpropoxy)-)
• 3289-43-8(6-ethoxypyrimidin-4-amine)
• 174886-02-3(4-PYRIMIDINAMINE, 6-(DIFLUOROMETHOXY)-2-METHOXY-)